These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12427496)

  • 21. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HFE genotype in patients with hemochromatosis and other liver diseases.
    Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
    Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene.
    Koziol JA; Ho NJ; Felitti VJ; Beutler E
    Clin Chem; 2001 Oct; 47(10):1804-10. PubMed ID: 11568090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
    Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O
    Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
    Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
    Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of
    Singal M; Mahmoud A; Phatak PD
    Expert Rev Hematol; 2024; 17(4-5):145-152. PubMed ID: 38551816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HFE based re-evaluation of heterozygous hemochromatosis.
    Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
    Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of HFE mutations among Turkish blood donors according to transferrin saturation: genotype screening for hereditary hemochromatosis among voluntary blood donors in Turkey.
    Simsek H; Sumer H; Yilmaz E; Balaban YH; Ozcebe O; Hascelik G; Buyukask Y; Tatar G
    J Clin Gastroenterol; 2004 Sep; 38(8):671-5. PubMed ID: 15319650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet counts in
    Barton JC; Barton JC; Acton RT
    Platelets; 2023 Dec; 34(1):2217933. PubMed ID: 37260121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V; Ryan E; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women.
    Rossi E; Olynyk JK; Cullen DJ; Papadopoulos G; Bulsara M; Summerville L; Powell LW
    Clin Chem; 2000 Feb; 46(2):162-6. PubMed ID: 10657371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis.
    Bittencourt PL; Palácios SA; Couto CA; Cançado EL; Carrilho FJ; Laudanna AA; Kalil J; Gayotto LC; Goldberg AC
    Braz J Med Biol Res; 2002 Mar; 35(3):329-35. PubMed ID: 11887210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
    Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
    Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does bilirubin protect against hemochromatosis gene (HFE) related mortality?
    Alizadeh BZ; Njajou OT; Houwing-Duistermaat JJ; de Jong G; Vergeer JM; Hofman A; Pols HA; van Duijn CM
    Am J Med Genet A; 2004 Aug; 129A(1):39-43. PubMed ID: 15266614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.